An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

Michèle Vacca(University of Cambridge), Ioannis Kamzolas(European Bioinformatics Institute), Lea Mørch Harder(Novo Nordisk (Denmark)), Fiona Oakley(Newcastle University), Christian Trautwein(RWTH Aachen University), Maximilian Hatting(RWTH Aachen University), Trenton T. Ross(Pfizer (United States)), Barbara Bernardo(Pfizer (United States)), Anouk Oldenburger(Boehringer Ingelheim (Germany)), Sara Toftegaard Hjuler(Novo Nordisk (Denmark)), Iwona Ksiazek(Novartis (Switzerland)), Daniel Lindén(AstraZeneca (Sweden)), Detlef Schuppan(Johannes Gutenberg University Mainz), Sergio Rodríguez‐Cuenca(University of Cambridge), Maria Manuela Tonini(Luxembourg Institute of Health), Tamara R. Castañeda(Sanofi (Germany)), Aimo Kannt(Goethe University Frankfurt), Cecília M. P. Rodrigues(University of Lisbon), Simon Cockell(Newcastle University), Olivier Govaere(Newcastle University), Ann K. Daly(Newcastle University), Michael Allison(Cambridge University Hospitals NHS Foundation Trust), Kristian Honnens de Lichtenberg(Novo Nordisk (Denmark)), Yong Ook Kim(Johannes Gutenberg University Mainz), Anna Lindblom(AstraZeneca (Sweden)), Stephanie Oldham(AstraZeneca (United States)), Anne‐Christine Andréasson(AstraZeneca (Sweden)), Franklin Schlerman(Pfizer (United States)), Jonathon Marioneaux, Arun J. Sanyal(Virginia Commonwealth University), Marta B. Afonso(University of Lisbon), Ramy Younes(Boehringer Ingelheim (Germany)), Yuichiro Amano(Takeda (Japan)), Scott L. Friedman(Icahn School of Medicine at Mount Sinai), Shuang Wang(Icahn School of Medicine at Mount Sinai), Dipankar Bhattacharya(Icahn School of Medicine at Mount Sinai), Eric J. Simon(Boehringer Ingelheim (Germany)), Valérie Paradis(Délégation Paris 7), Alastair D. Burt(Newcastle upon Tyne Hospital), Ioanna Maria Grypari(National and Kapodistrian University of Athens), Susan Davies(Cambridge University Hospitals NHS Foundation Trust), Ann Driessen(University of Antwerp), Hiroaki Yashiro(Takeda (United States)), Susanne Elisabeth Pors(Gubra (Denmark)), M Andersen(Gubra (Denmark)), Michael Feigh(Gubra (Denmark)), Carla Yunis(Pfizer (United States)), Pierre Bédossa(Newcastle University), Michelle Stewart(Mary Lyon Centre at MRC Harwell), Heather Cater(Mary Lyon Centre at MRC Harwell), Sara Wells(Mary Lyon Centre at MRC Harwell), Jörn M. Schattenberg(Saarland University), Quentin M. Anstee(Newcastle upon Tyne Hospital), The LITMUS Investigators(Newcastle upon Tyne Hospital), Quentin M. Anstee(Newcastle upon Tyne Hospital), Ann K. Daly(Newcastle University), Simon Cockell(National and Kapodistrian University of Athens), Dina Tiniakos(National and Kapodistrian University of Athens), Pierre Bédossa(Newcastle upon Tyne Hospital), Alastair D. Burt(Newcastle upon Tyne Hospital), Fiona Oakley(Newcastle University), Heather J. Cordell(Newcastle University), Christopher P. Day(Newcastle University), Kristy Wonders(Newcastle University), Paolo Missier(Newcastle University), Matthew McTeer(Newcastle University), Luke Vale(Newcastle University), Yemi Oluboyede(Newcastle University), Matt Breckons(Newcastle University), Jo Boyle(Newcastle University), Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij(Fondation pour l’innovation en Cadiométabolisme et Nutrition), Vlad Ratziu(Fondation pour l’innovation en Cadiométabolisme et Nutrition), Karine Clément(Fondation pour l’innovation en Cadiométabolisme et Nutrition), Rafael Patiño‐Navarrete(Fondation pour l’innovation en Cadiométabolisme et Nutrition), Raluca Pais(Hôpital Beaujon), Valérie Paradis(Délégation Paris 7), Detlef Schuppan(Johannes Gutenberg University Mainz), Jörn M. Schattenberg(Johannes Gutenberg University Mainz), Rambabu Surabattula(Johannes Gutenberg University Mainz), Sudha Rani Myneni(Johannes Gutenberg University Mainz), Yong Ook Kim(Johannes Gutenberg University Mainz), Beate K. Straub(Johannes Gutenberg University Mainz), Antonio Vidal-Puig(University of Cambridge), Michèle Vacca(University of Cambridge), Sergio Rodrigues-Cuenca(University of Cambridge), Mike Allison(University of Cambridge), Ioannis Kamzolas(European Bioinformatics Institute), Evangelia Petsalaki(European Bioinformatics Institute), Mark Campbell(University of Cambridge), Chris Lelliott(University of Cambridge), Susan Davies(Örebro University), Matej Orešič(Örebro University), Tuulia Hyötyläinen(Örebro University), Aidan McGlinchey(Örebro University), José M. Mato(CIC bioGUNE), Óscar Millet(University of Bern), Jean‐François Dufour(University of Bern), Annalisa Berzigotti(University of Bern), Mojgan Masoodi(University of Bern), Naomi F. Lange(University of Bern), Michael Pavlides(University of Oxford), Stephen Harrison(University of Oxford), Stefan Neubauer(University of Oxford), Jeremy Cobbold(University of Oxford), Ferenc E. Mózes(University of Oxford), Salma Akhtar(University of Oxford), Seliat Olodo-Atitebi(University of Oxford), Rajarshi Banerjee, Elizabeth Shumbayawonda, Andrea Dennis, Anneli Andersson, Ioan Wigley(Andalusian Health Service), Manuel Romero‐Gómez(Andalusian Health Service), Emilio Gómez-González(Andalusian Health Service), Javier Ampuero(Andalusian Health Service), Javier Castell(Andalusian Health Service), Rocío Gallego‐Durán(Andalusian Health Service), Isabel Fernández-Lizaranzu(Andalusian Health Service), Rocío Montero‐Vallejo(Andalusian Health Service), M.A. Karsdal(Nordic Bioscience (Denmark)), Daniel Guldager Kring Rasmussen(Nordic Bioscience (Denmark)), Diana Julie Leeming(Nordic Bioscience (Denmark)), Antonia Sinisi(Nordic Bioscience (Denmark)), Kishwar Musa(Central Bank of Luxembourg), Estelle Sandt(Central Bank of Luxembourg), Maria Manuela Tonini(Luxembourg Institute of Health), Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi(University of Florence), Fabio Marra(Consorzio Roma Ricerche), Amalia Gastaldelli(Marche Polytechnic University), Gianluca Svegliati(Marche Polytechnic University), Jérôme Boursier(Antwerp University Hospital), Sven Francque(Antwerp University Hospital), Luisa Vonghia(Antwerp University Hospital), An Verrijken(Antwerp University Hospital), Eveline Dirinck(Antwerp University Hospital), Ann Driessen(Linköping University), Mattias Ekstedt(Linköping University), Stergios Kechagias(Linköping University), Hannele Yki‐Järvinen(University of Helsinki), Kimmo Porthan(University of Helsinki), Johanna Arola(University of Helsinki), Saskia W. C. van Mil(National and Kapodistrian University of Athens), George Papatheodoridis(University of Lisbon), Helena Cortez‐Pinto(University of Lisbon), Ana Paula Silva(University of Lisbon), Cecília M. P. Rodrigues(University of Lisbon), Luca Valenti(University of Milan), Serena Pelusi(University of Milan), Salvatore Petta(University of Palermo), Grazia Pennisi(Università Cattolica del Sacro Cuore), Luca Miele(Università Cattolica del Sacro Cuore), Antonio Liguori(Università Cattolica del Sacro Cuore), Andreas Geier(Universitätsklinikum Würzburg), Monika Rau(Universitätsklinikum Aachen), Christian Trautwein(Universitätsklinikum Aachen), Johanna Reißing(University of Nottingham), Guruprasad P. Aithal(University of Nottingham), Susan Francis(University of Nottingham), Naaventhan Palaniyappan(University of Nottingham), Christopher R. Bradley(University of Nottingham), Paul Hockings(Antaros Medical (Sweden)), Moritz Schneider(University Hospitals Birmingham NHS Foundation Trust), Philip N. Newsome(University Hospitals Birmingham NHS Foundation Trust), Stefan G. Hübscher(University Hospitals Birmingham NHS Foundation Trust), David Wenn(iXscient), Jérémy Magnanensi(Genfit (France)), Aldo Trylesinski(Intercept Pharmaceuticals (United States)), Rebeca Mayo, Cristina Alonso(Eli Lilly (United States)), Kevin L. Duffin(Eli Lilly (United States)), James W. Perfield(Eli Lilly (United States)), Yu Chen(Eli Lilly (United States)), Mark L. Hartman(Eli Lilly (United States)), Carla Yunis(Pfizer (United States)), Melissa Miller(Pfizer (United States)), Yan Chen(Eli Lilly (United States)), Euan McLeod(Pfizer (United States)), Trenton T. Ross(Pfizer (United States)), Barbara Bernardo(Boehringer Ingelheim (Germany)), Corinna Schölch(Boehringer Ingelheim (Germany)), Judith Ertle(Boehringer Ingelheim (Germany)), Ramy Younes(Boehringer Ingelheim (Germany)), Harvey O. Coxson(Boehringer Ingelheim (Germany)), Eric Simon(Boehringer Ingelheim (Germany)), Joseph Gogain(SomaLogic (United States)), Rachel Ostroff(SomaLogic (United States)), Leigh Alexander(SomaLogic (United States)), Hannah Biegel(Novo Nordisk (Denmark)), Mette Skalshøi Kjær(Novo Nordisk (Denmark)), Lea Mørch Harder(Novo Nordisk (Denmark)), Naba Al‐Sari(Novo Nordisk (Denmark)), Sanne Skovgård Veidal(Novo Nordisk (Denmark)), Anouk Oldenburger(Boehringer Ingelheim (Germany)), Jens Ellegaard(Novartis (Switzerland)), M.M. Balp(Novartis (Switzerland)), Lori L. Jennings(Novartis (Switzerland)), Miljen Martić(Novartis (Switzerland)), Jürgen Löffler(Novartis (Switzerland)), Douglas Applegate(Novartis (Switzerland)), Richard Torstenson(AstraZeneca (Sweden)), Daniel Lindén(AstraZeneca (Sweden)), Céline Fournier‐Poizat, Anne Llorca, Michael Kalutkiewicz, Kay Pepin, Richard Ehman(Bristol-Myers Squibb (United States)), Gerald Horan(Bristol-Myers Squibb (United States)), Gideon Ho(Histoindex (Singapore)), Dean Tai(Histoindex (Singapore)), Elaine Chng(Histoindex (Singapore)), Teng Xiao(Gilead Sciences (United States)), Scott D. Patterson(Gilead Sciences (United States)), Andrew N. Billin(RTI International), Lynda Doward(RTI International), James Twiss(RTI International), Paresh Thakker(Takeda (Japan)), Zoltán Derdák(Takeda (Japan)), Hiroaki Yashiro(AbbVie (United States)), Henrik Landgren(Medical University of Graz), Carolin Lackner(University of Groningen), Annette S.H. Gouw(University of Groningen), Prodromos Hytiroglou(Aristotle University of Thessaloniki), Olivier Govaere(HiFiBiO Therapeutics (France)), Clifford A. Brass(HiFiBiO Therapeutics (France)), Dina Tiniakos(Eli Lilly (United States)), James W. Perfield(Eli Lilly (United States)), Evangelia Petsalaki(European Bioinformatics Institute), Peter K. Davidsen(Novo Nordisk (Denmark)), Antonio Vidal-Puig(Wellcome/MRC Institute of Metabolic Science)
Nature Metabolism
June 12, 2024
Cited by 219Open Access
Full Text

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, encompasses steatosis and metabolic dysfunction-associated steatohepatitis (MASH), leading to cirrhosis and hepatocellular carcinoma. Preclinical MASLD research is mainly performed in rodents; however, the model that best recapitulates human disease is yet to be defined. We conducted a wide-ranging retrospective review (metabolic phenotype, liver histopathology, transcriptome benchmarked against humans) of murine models (mostly male) and ranked them using an unbiased MASLD 'human proximity score' to define their metabolic relevance and ability to induce MASH-fibrosis. Here, we show that Western diets align closely with human MASH; high cholesterol content, extended study duration and/or genetic manipulation of disease-promoting pathways are required to intensify liver damage and accelerate significant (F2+) fibrosis development. Choline-deficient models rapidly induce MASH-fibrosis while showing relatively poor translatability. Our ranking of commonly used MASLD models, based on their proximity to human MASLD, helps with the selection of appropriate in vivo models to accelerate preclinical research.


Related Papers

No related papers found

Powered by citation graph analysis